The Arix Bioscience (LON:ARIX) share price has risen by 14.6% over the past month and it’s currently trading at 193.19. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will c...
ARIX — Arix Bioscience Share Price
0.000.00%
Last trade - 00:00FinancialsSpeculativeSmall CapNeutral
- £157.66m
- £48.23m
- £0.48m
- 29
- 50
- 16
- 22
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.56 | ||
| Price to Tang. Book | 0.56 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 336.88 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -2.56% | ||
| Return on Equity | 14.61% | ||
| Operating Margin | -1536.32% | ||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 0.64 | 1.86 | 1.33 | 0.51 | 0.48 | n/a | n/a | 243.32% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health Trend(F-Score)
12345678910
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Latest News & Insights for ARIX
The Arix Bioscience (LON:ARIX) share price has risen by 68.1% over the past month and it’s currently trading at 177. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will cont...
The Arix Bioscience (LON:ARIX) share price has risen by 46.5% over the past month and it’s currently trading at 162.25. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will c...
The Arix Bioscience (LON:ARIX) share price has risen by 12.5% over the past month and it’s currently trading at 109. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will cont...
The Arix Bioscience (LON:ARIX) share price has risen by 35.0% over the past month and it’s currently trading at 108.3901. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will...
Profile Summary
Arix Bioscience plc is a United Kingdom-based venture capital company that is focused on investing in and building biotechnology companies around advances in life sciences. The Company is a holding company that is focused on generating value from the development and commercialization of technologies and discoveries. The Company's principal activity is to source, finance and develop healthcare and life science businesses across the world. The Company focuses on acquiring interests in, and provide operational oversight to, healthcare and life science businesses with which it partners in the healthcare and life science sector. The Company’s portfolio includes Harpoon Therapeutics, Inc. (HARP), Artios Pharma Ltd (Artios), Aura Biosciences Inc (Aura), LogicBio Therapeutics, Inc. (LOGC). The Company's subsidiaries include Depixus SAS (EUR), Quench Bio, Inc., Stipe Therapeutics Aps and Twelve Bio Aps.
Directors
- Naseem Amin CHM (59)
- Robert Lyne CEO
- Marcus Karia FID
- Mark Chin MDR (39)
- Tim Xu OTH
- James Noble NED
- Axel Wieandt NED
- Michael Bunbury NID (73)
- Trevor Jones NID (77)
- Last Annual
- December 31st, 2020
- Last Interim
- June 30th, 2021
- Incorporated
- September 15th, 2015
- Public Since
- February 17th, 2017
- No. of Employees
- 330
- Sector
- Investment Banking & Investment Services
- Industry
- Financials
- Exchange
- London Stock Exchange
- Shares in Issue
- 129,229,471
- Address
- 20 Berkeley Square, LONDON, W1J 6EQ
- Web
- https://arixbioscience.com/
- Phone
- +44 2072901050
- Auditors
- BDO LLP
Latest News for ARIX
Upcoming Events for ARIX
Full Year 2021 Arix Bioscience PLC Earnings Release
Arix Bioscience PLC Annual Shareholders Meeting
Similar to ARIX
3i
London Stock Exchange
Abrdn
London Stock Exchange
Adams
London Stock Exchange
Agronomics
London Stock Exchange
AJ Bell
London Stock Exchange
FAQ
What is the Arix Bioscience share price?
As of Today at 12:11 UTC, shares in Arix Bioscience are trading at 122.00p. This share price information is delayed by 15 minutes.
How has the Arix Bioscience share price performed this year?
Shares in Arix Bioscience last closed at 122.00p and the price had moved by -29.28% over the past 365 days. In terms of relative price strength the Arix Bioscience share price has underperformed the FTSE All Share Index by -36.5% over the past year.
What are the analyst and broker recommendations for Arix Bioscience?
The overall consensus recommendation for Arix Bioscience is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Arix Bioscience dividend yield?
Arix Bioscience does not currently pay a dividend.
Does Arix Bioscience pay a dividend?
Arix Bioscience does not currently pay a dividend.
When does Arix Bioscience next pay dividends?
Arix Bioscience does not currently pay a dividend.
How do I buy Arix Bioscience shares?
To buy shares in Arix Bioscience you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Arix Bioscience?
As of the previous close price of 122.00p, shares in Arix Bioscience had a market capitalisation of £157.66m.
Where are Arix Bioscience shares listed?
Here are the trading details for Arix Bioscience:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: ARIX
What kind of share is Arix Bioscience?
Based on an overall assessment of its quality, value and momentum Arix Bioscience is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Arix Bioscience share price forecast for 2022?
The analyst consensus target price for shares in Arix Bioscience is 218.50p. That is 79.1% above the last closing price of 122.00p.
Analysts covering Arix Bioscience currently have a consensus Earnings Per Share (EPS) forecast of -£0.14 for the next financial year.
What is the trend in the Arix Bioscience share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Arix Bioscience. Over the past six months, its share price has underperformed the FTSE All Share Index by -32.76%.
As of the last closing price of 122.00p, shares in Arix Bioscience were trading -23.12% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Arix Bioscience PE Ratio?
The Arix Bioscience PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at 122.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Arix Bioscience?
Arix Bioscience's management team is headed by:
- Naseem Amin - CHM
- Robert Lyne - CEO
- Marcus Karia - FID
- Mark Chin - MDR
- Tim Xu - OTH
- James Noble - NED
- Axel Wieandt - NED
- Michael Bunbury - NID
- Trevor Jones - NID